Olema Pharmaceuticals names Jason O’Byrne CFO

Reuters2026/08/13 11:05

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Olema Pharmaceuticals named Jason O’Byrne chief financial officer as it prepares for pivotal OPERA-01 data and a potential first commercial launch.
O’Byrne most recently served as executive vice president and CFO at Vir Biotechnology, overseeing finance, investor relations, information technology.
He previously was CFO at Caribou Biosciences, leading capital markets work including its IPO.
Earlier roles included senior vice president of finance at Audentes Therapeutics, supporting integration of its USD 3 billion acquisition by Astellas.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Olema Pharmaceuticals Inc. published the original content used to generate this news brief on August 13, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Olema Pharmaceuticals names Jason O’Byrne CFO

You may also like

Crypto prices